Strain SummarySTOCK E2f3tm5(E2f1)Gle
Strain Name |
STOCK E2f3tm5(E2f1)Gle |
Strain Type(s) |
targeted mutation (knock-in) |
Strain Synonym(s) |
1+/+3a1KI/1KI • 3a1KI/1KI • E2f1+/+ E2f3a1KI/1KI • E2f3a1KI/1KI |
Description |
Homozygous mice. This STOCK background was a mixture of "FVB/NT" [Note: The "T" may be an erroneous indication of Taconic, lab code "Tac".], "129v/Sv", and "C57BL/Swiss". |
Strain Genetics |
E2f3tm5(E2f1)Gle / E2f3tm5(E2f1)Gle |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Liver adenoma | Liver |
6.25 |
4.3 |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
||||
| Liver hepatocellular carcinoma | Liver |
64 |
87.5 |
70 |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
|||
| Liver hepatocellular carcinoma | Liver | diethylnitrosamine (DEN) |
80 |
100 |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
|||
| Liver tumor | Liver |
94 |
observed |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
||||
| Liver tumor | Liver | polyinosinic/polycytidylic acid (pIpC) (poly I:C) |
observed |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
||||